Effects of creep feeding, zeranol implants and breed type on beef production: II. Reproductive development and fat deposition in heifers.
Effects of preweaning creep feeding and zeranol implants on reproductive tract development and udder and s.c. fat deposition were studied in 24 weanling heifers (7 mo of age) with Brahman and Romana Red sires and Angus and Angus x Brown Swiss F1 reciprocal crossbred dams. Creep treatment did not affect (P greater than .19) ovarian weight, ovarian size, uterine horn diameter or follicle number. Heifers from the three creep treatments did not differ (P greater than .25) in udder weight, total lipid or percentage of lipid in the udder. Noncreep-fed (NC) heifers had a greater (P less than .02) number of adipocytes/gram of udder tissue than did the long-term creep-fed (LC) and short-term creep-fed (SC) heifers. The LC heifers had larger udder (166.0 vs 152.7 m) and s.c. adipocytes (166.7 vs 148.8 m) than NC heifers. Heifers implanted with zeranol at 56 and 146 d of age had a greater (P less than .03) uterine horn diameter and heavier (P less than .02) uterine weight than unimplanted heifers. Percentage of lipid in the udder was lower (P less than .02) in heifers implanted with zeranol. Implanted heifers had smaller (P less than .10) s.c. adipocytes than unimplanted heifers. Breed of dam did not effect (P greater than .17) development of the reproductive tract of weanling heifers. Heifers from Angus dams had smaller (P less than .08) udders and less (P less than .10) total fat in the udder than those from F1 dams, and the heifers from F1 dams tended (P less than .12) to have larger udder adipocytes.(ABSTRACT TRUNCATED AT 250 WORDS)
Prichard
D L
DL
University of Florida, Gainesville 32611.
Marshall
T T
TT
Hargrove
D D
DD
Olson
T A
TA
D000273:Adipose Tissue / Q000166:cytology; D000821:Animal Feed; D000818:Animals; D001823:Body Composition / Q000187:drug effects; D002417:Cattle / Q000254:growth & development*; D002452:Cell Count / Q000662:veterinary; D004343:Drug Implants; D005260:Female; D005298:Fertility; D008055:Lipids / Q000032:analysis; D008321:Mammary Glands, Animal / Q000166:cytology / Q000254:growth & development*; D009929:Organ Size / Q000187:drug effects; D006080:Ovarian Follicle / Q000502:physiology; D010053:Ovary / Q000254:growth & development*; D012118:Resorcinols / Q000494:pharmacology*; D014599:Uterus / Q000254:growth & development*; D015029:Zeranol / Q000008:administration & dosage / Q000494:pharmacology*
D004343:Drug Implants; D008055:Lipids; D012118:Resorcinols; D015029:Zeranol